Over the last 12 hours, Rhode Island–relevant coverage skewed toward health, local business moves, and broader technology policy. A new study published in Neurology reports an association between calcitonin gene-related peptide (CGRP) migraine prevention drugs and a reduced risk of glaucoma (the article stresses it does not prove causation). In Providence, Brightstar Lottery signed a long-term lease extension for its downtown headquarters at 10 Memorial Blvd., extending occupancy through at least July 2036. The same window also included a Rhode Island–connected AI/tech policy story: an AP report on the ongoing trial between Elon Musk and OpenAI’s leadership highlights how “worries about AI’s risks to humanity” have surfaced in testimony, even though the technology itself is not on trial.

Technology and science coverage also appeared in the last 12 hours, but not all of it is Rhode Island-specific. An AP report describes a newly confirmed offshore freshwater aquifer system off the New England coast, led by co-chief scientists including Rebecca Robinson of the University of Rhode Island—an example of how regional research institutions are tied to major environmental findings. There was also a health/technology-adjacent local angle in coverage of how young people are using AI for sensitive guidance: a Rhode Island College student quoted in a story says teens sometimes confide in AI for relationship/sexual health reassurance, raising concerns about losing human connection and receiving overly affirming answers.

Beyond Rhode Island, the most prominent “big theme” in the last 12 hours is AI risk and governance. The Musk–OpenAI trial coverage repeatedly frames the dispute around the question of how to protect humanity from AI risks, with witness testimony touching workforce disruption, misinformation, and other harms. That theme connects to older coverage in the 3–7 day range about AI being integrated into high-stakes environments (including reports that the U.S. military reached AI deals with multiple tech companies for classified systems), suggesting a continuing news thread about AI deployment outpacing public safeguards.

Older material from the 12 to 72 hours and 3–7 day windows provides continuity on policy and compliance issues that can affect Rhode Island organizations. For example, coverage in the 24–72 hour range notes a CMS transition affecting Medicare DMEPOS appeals and rebuttals (with NPE contractors taking over starting May 8), and other items in the same period point to ongoing legal and regulatory friction around DEI-adjacent practices. Taken together with the recent AI-risk trial coverage, the overall pattern is that technology—especially AI—remains a central driver of both legal scrutiny and practical operational change, while Rhode Island-specific business and health updates continue to appear alongside it.